iRhythm Holdings, Inc. (IRTC) Operating Margin
- Operating margin · 12 months: Value -3.01%; Formula and calculation Operating income / revenue. Period ending 2026-06-30..
Operating margin
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Operating margin · 12 months | -3.01% | Operating income / revenue. Period ending 2026-06-30. $-24.87M ÷ $825.34M × 100 ≈ -3.01% |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Operating income | -24.87M USD | Operating Income (Loss) |
| Revenue | 825.34M USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Cost of products and services | (m) | |
| Research and development | (m) | Research and Development Expense |
| Selling, general and administration | 513.76M USD | Selling, General and Administrative Expense |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Operating income (USD) | Revenue (USD) | Cost of products and services (USD) | Research and development (USD) | Selling, general and administration (USD) | Operating margin |
|---|---|---|---|---|---|---|
| 2026-06-30 | $-24.87M | $825.34M | (m) | (m) | $513.76M | -3.01% |
| 2026-03-31 | $-41.04M | $787.85M | (m) | (m) | $508.48M | -5.21% |
| 2025-12-31 | $-57.41M | $747.14M | (m) | (m) | $492.55M | -7.68% |
| 2025-09-30 | $-63.78M | $702.57M | (m) | (m) | $470.32M | -9.08% |
| 2025-06-30 | $-105.65M | $657.23M | (m) | (m) | $449.48M | -16.08% |
| 2025-03-31 | $-109.92M | $618.59M | (m) | (m) | $429.86M | -17.77% |
| 2024-12-31 | $-115.50M | $591.84M | (m) | (m) | $418.56M | -19.52% |
| 2024-09-30 | $-150.60M | $560.02M | (m) | (m) | $418.91M | -26.89% |
| 2024-06-30 | $-127.90M | $537.09M | (m) | $68.41M | $409.30M | -23.81% |
| 2024-03-31 | $-123.80M | $513.17M | (m) | $62.40M | $393.96M | -24.12% |
| 2023-12-31 | $-125.16M | $492.68M | (m) | $60.24M | $385.64M | -25.40% |
| 2023-09-30 | $-106.68M | $472.79M | (m) | $57.50M | $372.26M | -22.56% |
| 2023-06-30 | $-100.16M | $452.06M | (m) | $52.64M | $359.05M | -22.16% |
| 2023-03-31 | $-104.74M | $429.98M | (m) | $50.91M | $349.38M | -24.36% |
| 2022-12-31 | $-113.78M | $410.92M | (m) | $46.61M | $322.20M | -27.69% |
| 2022-09-30 | $-125.28M | $380.11M | (m) | $45.80M | $307.08M | -32.96% |
| 2022-06-30 | $-127.48M | $361.67M | (m) | $43.04M | $297.27M | -35.25% |
| 2022-03-31 | $-121.02M | $340.89M | (m) | $40.70M | $278.18M | -35.50% |
| 2021-12-31 | $-99.94M | $322.82M | (m) | $38.67M | $274.84M | -30.96% |
| 2021-09-30 | $-77.33M | $319.83M | (m) | $38.41M | $259.51M | -24.18% |
| 2021-06-30 | $-58.80M | $306.34M | (m) | $38.49M | $238.47M | -19.19% |
| 2021-03-31 | $-61.97M | $275.94M | (m) | $41.42M | $218.82M | -22.46% |
| 2020-12-31 | $-43.67M | $265.17M | (m) | $41.33M | $197.23M | -16.47% |
| 2020-09-30 | $-51.82M | $245.46M | (m) | $38.99M | $194.59M | -21.11% |
| 2020-06-30 | $-65.32M | $228.19M | (m) | $43.72M | $190.54M | -28.63% |
| 2020-03-31 | $-55.72M | $229.75M | (m) | $39.02M | $189.69M | -24.25% |
| 2019-12-31 | $-54.76M | $214.55M | (m) | $37.30M | $179.52M | -25.52% |
| 2019-09-30 | $-50.12M | $197.23M | (m) | $35.12M | $162.86M | -25.41% |
| 2019-06-30 | $-40.60M | $181.80M | (m) | $27.56M | $149.81M | -22.33% |
| 2019-03-31 | $-40.95M | $163.94M | (m) | $23.49M | $139.71M | -24.98% |
| 2018-12-31 | $-43.62M | $147.29M | (m) | $20.75M | $131.58M | -29.61% |
| 2018-09-30 | $-42.69M | $132.32M | (m) | $17.89M | $121.36M | -32.26% |
| 2018-06-30 | $-38.93M | $119.25M | (m) | $16.52M | $108.93M | -32.64% |
| 2018-03-31 | $-33.17M | $107.64M | (m) | $14.73M | $96.09M | -30.81% |
| 2017-12-31 | $-27.27M | $98.51M | (m) | $13.34M | $84.74M | -27.68% |
| 2017-09-30 | $-21.00M | $89.03M | (m) | $11.49M | $72.75M | -23.58% |
| 2017-06-30 | $-17.68M | $80.78M | (m) | $9.34M | $64.97M | -21.89% |
| 2017-03-31 | $-15.46M | $72.66M | (m) | $8.23M | $57.32M | -21.27% |
| 2016-12-31 | $-15.58M | $64.07M | (m) | $7.15M | $51.62M | -24.32% |
| 2016-09-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2016-06-30 | (m) | $48.79M | (m) | (m) | (m) | (m) |
| 2016-03-31 | (m) | $41.94M | (m) | (m) | (m) | (m) |
| 2015-12-31 | $-21.63M | $36.14M | (m) | $6.35M | $36.72M | -59.85% |
| 2015-09-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2015-06-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2015-03-31 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2014-12-31 | $-14.77M | $21.75M | (m) | $5.70M | $20.23M | -67.89% |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PULSE BIOSCIENCES, INC. (PLSE) | United States | $3.696B | -24.47 |
| ICU MEDICAL INC/DE (ICUI) | United States | $4.153B | 18.85 |
| AtriCure, Inc. (ATRC) | United States | $3.089B | |
| Heartflow, Inc. (HTFL) | United States | $4.225B | |
| HAEMONETICS CORP (HAE) | United States | $4.821B | 36.52 |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |
| NovoCure Ltd (NVCR) | $1.886B | -11.87 |